Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment

PDF  |  How to cite

Oncotarget. 2018; 9:35285-35285. https://doi.org/10.18632/oncotarget.26255

Metrics: PDF 1227 views  |   ?  

Hongjuan Zhang1,2, Cheng Zhan2, Ji Ke3, Zhiqiang Xue4, Aiqun Zhang4, Kaifeng Xu5, Zhirong Shen2,6, Lei Yu3 and Liang Chen2,7

1 School of Life Science, Tsinghua University, Beijing 100084, China
2 National Institute of Biological Sciences, Beijing 102206, China
3 Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
4 The General Hospital of People’s Liberation Army (301 Hospital), Beijing 100853, China
5 Peking Union Medical College Hospital, Beijing 100730, China
6 Collaborative Innovation Center of Systems Biomedicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China
7 National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, 102206, China

Published: October 16, 2018

This article has been corrected: The correct Acknowledgment information is given below:


This work was funded by National Natural Science Foundation of China grant 81472606, Chinese Ministry of Science and Technology grant (973 grant) 2011CB812401, and the Beijing Municipal Government.

Original article: Oncotarget. 2016; 7:3367-3378. DOI: https://doi.org/10.18632/oncotarget.6491.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26255